Last Update Time:
28-Feb-2025 16:00:00
ISIN:
INE385W01011
Sector:
Healthcare
Symbol:
DCAL
Dishman Carbogen Amcis Limited
₹199.00
₹-7.55
(-3.66%)
▼
Prev. Close
₹206.55
Open
₹203.95
Close
₹199.20
Range
₹189.05 - ₹208.95
High
₹210.81
Low
₹196.77
Ind. Close
₹0.00
VWAP
₹200.59
The current stock price of Dishman Carbogen Amcis Limited is ₹199.00, with a target price range between ₹189.05 and ₹208.95. The stock has experienced a price change of ₹-7.55 (-3.66%), reflecting recent market volatility.
Today's opening price was ₹203.95, while the previous close stood at ₹206.55.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Dishman Carbogen Amcis Limited Price Chart
Dishman Carbogen Amcis Limited Pre Open Market Overview: 28-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 203.95
- Previous Close Price: 206.55
- Change: -2.60%
- Total Traded Volume: 558
- Total Buy Quantity: 5,877
- Total Sell Quantity: 4,980
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 202.01 | 100.00 | 0.00 |
| 202.10 | 46.00 | 0.00 |
| 203.00 | 2.00 | 0.00 |
| 203.30 | 3.00 | 0.00 |
| 203.45 | 774.00 | 0.00 |
| 203.50 | 0.00 | 198.00 |
| 203.95 | 0.00 | 20.00 |
| 204.00 | 0.00 | 250.00 |
| 205.00 | 0.00 | 250.00 |
| 206.30 | 0.00 | 10.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 5877
Total Sell Quantity: 4980
Shareholding Patterns of Dishman Carbogen Amcis Limited
Key Trade Statistics of Dishman Carbogen Amcis Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 3.00 |
| Traded Value (₹ Cr.) | 6.03 |
| Total Market Cap (₹ Cr.) | 3,119.98 |
| Free Float Market Cap (₹ Cr.) | 1,268.34 |
| Impact cost | 0.12 |
| Quantity Traded | 300,410.00 |
| Deliverable Quantity | 126,417.00 |
| % of Quantity to Traded | 42.08 |
| Security VaR | 25.06 |
| Index VaR | N/A |
| VaR Margin | 25.06 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 28.56 |
| Face Value | 2 |
Key Price Statistics of Dishman Carbogen Amcis Limited
The 52-week high for Dishman Carbogen Amcis Limited was ₹307.98, recorded on 11-Dec-2024. On the other hand, the 52-week low stands at ₹133.00, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹247.86, and the lower band is ₹165.24. The price band is 20%.
The stock's daily volatility stands at 3.73, while the annualized volatility is 71.26. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (11-Dec-2024) | 307.98 |
| 52 Week Low (04-Jun-2024) | 133.00 |
| Upper Band | 247.86 |
| Lower Band | 165.24 |
| Price Band (%) | 20 |
| Daily Volatility | 3.73 |
| Annualised Volatility | 71.26 |
| Tick Size | 0.01 |
Key Securities Statistics of Dishman Carbogen Amcis Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 21-Sep-2017 |
| Adjusted P/E | 0 |
| Symbol P/E | 0 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Dishman Carbogen Amcis Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Dishman Carbogen Amcis Limited
| Subject | Date |
|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 13-Feb-2025 |
| Investor Presentation | 12-Feb-2025 |
| Integrated Filing- Financial | 12-Feb-2025 |
| Financial Result Updates | 12-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Feb-2025 |
| Board Meeting Intimation | 08-Feb-2025 |
| Shareholders meeting | 04-Feb-2025 |
Corporate Actions of Dishman Carbogen Amcis Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Dividend - Rs 0.20 Per Share | 12-Sep-2019 |
Board Meetings of Dishman Carbogen Amcis Limited
Financial Results of Dishman Carbogen Amcis Limited
Company Directory of Dishman Carbogen Amcis Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.dishmangroup.com | Registered Office | Dishman Corporate House, Iscon-Bopal Road, Ambli AHMEDABAD | AHMEDABAD |
Insider Trading of Dishman Carbogen Amcis Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Nikunj Desai | 571467 | Buy |
| 7(2) | Nikunj Desai | 55344 | Buy |
| 7(2) | Adimans Technologies LLP | 443194735 | Sell |
| 7(2) | Adimans Technologies LLP | 135267947 | Sell |
| 7(2) | Adimans Technologies LLP | 2720011 | Sell |
| 7(2) | Adimans Technologies LLP | 288901293 | Sell |
| 7(2) | Himani Sanjay Dhotre | 973964 | Buy |
| 7(2) | Adimans Technologies Private Limited | 0 | Sell |
| 7(2) | Adimans Technologies LLP | 0 | Buy |
Annual Reports of Dishman Carbogen Amcis Limited
Investor Complaints of Dishman Carbogen Amcis Limited
Event Calendar of Dishman Carbogen Amcis Limited
| Purpose | Details |
|---|---|
| Results | Inter alia, to consider and take on record the Un-Audited Financial Results of the Company for the quarter and half year ended on September 30, 2017. |
| Results | inter alia, to consider and take on record the Un-Audited Financial Results of the Company for the quarter ended on December 31, 2017. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | DCAL : 15-May-2019 : The Company has informed the Exchange that a Board meeting to be held on May 08, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 15, 2019, To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Buyback/Other business matters | To consider buyback for equity shares and a proposal of setting up of a Share Based Employee Benefit Scheme |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | DCAL : 08-Sep-2020 : The Company has informed the Exchange that a Board meeting to be held on August 13, 2020 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on September 08, 2020, To consider and approve the financial results for the period ended Jun 30, 2020. However, the scheduled Board Meeting will continue to be held on 13th August, 2020 to consider and approve the proposed Capital Expenditure at the Company s subsidiaries. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Other business matters | To consider other business matters toￂﾠconsiderￂﾠa proposal of setting up of a Share Based Employee Benefit Scheme and the matters connected or incidental therewith. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Dishman Carbogen Amcis Limited has informed the Exchange about Board Meeting to be held on 10-May-2022 to consider financial statements for the period ended March 2022 |
| Financial results | Dishman Carbogen Amcis Limited has informed the Exchange about Board Meeting to be held on 09-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Dishman Carbogen Amcis Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider financial statements for the period ended September 2022 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Fund Raising | To consider and approve the financial results for the period ended March 31, 2024 and Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Dishman Carbogen Amcis Limited
Voting Results of Dishman Carbogen Amcis Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 31-JAN-2025 | Postal Ballot | Confirmation of the appointment of Mr. Kulin N. Shah (DIN ￢ﾀﾓ 01863481), as an Independent Director for a first term of five consecutive years |
| 31-JAN-2025 | Postal Ballot | Approval for alteration of Object Clause of Memorandum of Association as per provisions of Companies Act, 2013 |
| 27-SEP-2024 | AGM | Reso. No. 1 (a): Adoption of Audited Standalone Financial Statements for the year ended March 31, 2024 and report of the Board of Directors and Auditors thereon. |
| 27-SEP-2024 | AGM | Reso. No. 3: Payment of remuneration pursuant to Regulation 17(6)(ca) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to Mr. Janmejay R. Vyas (DIN:00004730), Director of the Company for rendering professional service to the Company for the Financial Year 2024-25. |
| 27-SEP-2024 | AGM | Reso. No. 2: Re-appointment of a Director Mr. Arpit J. Vyas (DIN 01540057), who retires by rotation. |
| 27-SEP-2024 | AGM | Reso. No. 1 (b): Adoption of Audited Consolidated Financial Statements for the year ended March 31, 2024 and the report of the Auditors thereon. |
| 27-SEP-2023 | AGM | Reso. No. 1 (a): Adoption of Audited Standalone Financial Statements for the year ended March 31, 2023 and report of the Board of Directors and Auditors thereon. |
| 27-SEP-2023 | AGM | Reso. No. 6: Re-appointment of Mr. Arpit J. Vyas, as a Global Managing Director for a further period of 5 (five) years with effect from 1st June, 2024 and payment of remuneration within the parameters of the applicable laws and regulations or any amendments thereto. |
| 27-SEP-2023 | AGM | Reso. No. 5: Re-appointment of Ms. Maitri K. Mehta, as an Independent Director for a second term of 5 (five) consecutive years with effect from 1st April, 2024. |
| 27-SEP-2023 | AGM | Reso. No. 4: Payment of Remuneration by way of commission to Non-Executive Directors (including Independent Directors) for the financial year 2023-2024 to the financial year 2025-2026. |
| 27-SEP-2023 | AGM | Reso. No. 3: Payment of remuneration pursuant to Regulation 17(6)(ca) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to Mr. Janmejay R. Vyas (DIN:00004730), Director of the Company for rendering professional service to the Company for the Financial Year 2023-24. |
| 27-SEP-2023 | AGM | Reso. No. 2: Re-appointment of a Director Mr. Janmejay R. Vyas (DIN 00004730), who retires by rotation. |
| 27-SEP-2023 | AGM | Reso. No. 1 (b): Adoption of Audited Consolidated Financial Statements for the year ended March 31, 2023 and the report of the Auditors thereon. |
| 29-SEP-2022 | AGM | Reso. No. 1 (a): Adoption of Audited Standalone Financial Statements for the year ended March 31, 2022 and report of the Board of Directors and Auditors thereon. |
| 29-SEP-2022 | AGM | Reso. No. 3: Payment of remuneration pursuant to Regulation 17(6)(ca) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to Mr. Janmejay R. Vyas (DIN:00004730), Director of the Company for rendering professional service to the Company for the Financial Year 2022-23. |
| 29-SEP-2022 | AGM | Reso. No. 2: Re-appointment of a Director Mrs. Deohooti J. Vyas (DIN ￢ﾀﾓ 00004876), who retires by rotation. |
| 29-SEP-2022 | AGM | Reso. No. 1 (b): Adoption of Audited Consolidated Financial Statements for the year ended March 31, 2022 and the report of the Auditors thereon. |
| 19-JUL-2021 | AGM | Reso. No. 1 (a): Adoption of Audited Standalone Financial Statements for the year ended March 31, 2021 and report of the Board of Directors and Auditors thereon. |
| 19-JUL-2021 | AGM | Reso. No. 2: Re-appointment of a Director Mr. Arpit J. Vyas (DIN ￢ﾀﾓ 01540057), who retires by rotation. |
| 19-JUL-2021 | AGM | Reso. No. 1 (b): Adoption of Audited Consolidated Financial Statements for the year ended March 31, 2021 and the report of the Auditors thereon. |
FAQs on Dishman Carbogen Amcis Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.